[Home]   [Full version]  

New and Simple Test for Active Tuberculosis Now Possible

Sep 14 ,Medicine & Health


Tuberculosis (TB) is the number one cause of death by infection in the world today killing about two million people. Yet most deaths from TB are easily preventable by early diagnosis and treatment.

Many clinicians still rely on a diagnostic test that is over 100 years old. In research published in the Lancet today, Scientists at St George’s, University of London have come up with a new way of detecting TB using unique biomarkers. The test is 94% accurate and can be developed into a simple serum test.

Professor Sanjeev Krishna in the Centre for Infection and his team, in collaboration with the National Institute of Medical Research (UK), have been able to identify a complex signature in serum unique to TB that is not present in samples from other infections and lung diseases. Researchers were able to detect this unique signature using a mass spectrometer called a SELDI (surface-enhanced laser desorption and ionization time-of-flight spectrometer). They then used this signature to work out a simpler way to diagnose TB.

Currently, the diagnosis of TB involves looking at sputum with a microscope, which is often the only affordable and available test, but only achieves a sensitivity of 40 – 60% under field conditions. Sputum culture, which takes between 2 – 6 weeks to produce a result, is not routinely carried out in countries with a high prevalence of TB but helps to improve diagnostic yield. The key to reducing death rates in patients with TB, and to stopping transmission in resource poor countries, is to diagnose and start treatment in the first visit to the clinic.

Professor Sanjeev Krishna “We are putting forward a completely fresh approach to look at an ancient problem. I think it is going to be very exciting to make this work in clinics where a test for TB is desperately needed. The next stage will be to use the biomarkers we have identified to develop a cheap, accurate and rapid diagnostic test that can be used easily and quickly out in the field.”

Source: St George's Hospital Medical School

Related stories:

Researchers detect fake art from originals
As museums continue to digitize their art collections, it becomes increasingly easier for paintings to be forged. Two Penn State researchers are part of an international team working on a digital system to help detect original works from counterfeit ones.
Doctors can unmask deceptive high-risk breast tumors using genetic profile
A unique genetic signature can alert physicians to high-risk breast tumors that are masquerading as low-risk tumors, according to research at Washington University School of Medicine in St. Louis and collaborating institutions. Although these tumors are apparently estrogen-receptor positive — meaning they should depend on estrogen to grow — they don't respond well to anti-estrogen therapy.
Biomarkers identified for idiopathic pulmonary fibrosis
The first evidence of a distinctive protein signature that could help to transform the diagnosis and improve the monitoring of the devastating lung disease idiopathic pulmonary fibrosis (IPF) is being reported by University of Pittsburgh School of Medicine researchers in this month’s edition of PLoS Medicine, an open-access journal of the Public Library of Science.
Computer scientist forges new line of defense against malicious traffic
Paul Barford has watched malicious traffic on the Internet evolve from childish pranks to a billion-dollar "shadow industry" in the last decade, and his profession has largely been one step behind the bad guys.
Scientists search for brain center responsible for tinnitus
For the more than 50 million Americans who experience the phantom sounds of tinnitus -- ringing in the ears that can range from annoying to debilitating -- certain well-trained rats may be their best hope for finding relief.
WFU professor designs atomic emission detector
Brad Jones, a professor of chemistry at Wake Forest University, is leading a team of researchers at four institutions to develop the first handheld, field instrument capable of detecting and identifying radioactive particles at the site of potential contamination. The device will enable authorities to quickly test dust, soil, water and crops in the event of a terrorist attack such as a “dirty” bomb.
Researchers investigate tracking, sensors to assist Air Force
Two Louisiana Tech faculty members, Dr. Sumeet Dua, an assistant professor of computer science, and Dr. Rastko Selmic, an assistant professor of electrical engineering, are using their skills and technical knowledge to help the U.S. Air Force and Department of Defense with sensor networks and tracking capabilities.
A new century of Alzheimer's disease research
Imagine the day when a routine visit to the family doctor includes a simple blood test to predict the risk for developing Alzheimer’s disease (AD). If the test returns a worrisome result -- too many sticky brain proteins that might begin to gum up memory and thought in 10 to 15 years -- a person could be offered an aspirin-like pill to keep those proteins in check.

News discussion:

Medicine & Health news

[Home]   [Full version]